TP53 and colorectal carcinoma: In CRC, frequent mutations in both the PI3K pathway and the mitogen-activated protein kinase (MAPK) pathway promote tumor progression often alongside other common mutations in the wingless-type MMTV integration site family (WNT) signaling pathway, p53 and transforming growth factor beta (TGFβ) signaling pathways [19].